Recent news

May 2011

Clinical trial of microbicide ring enters final stage

May 23, 2011 -- This month, Project Ubuzima, with the International Partnership for Microbicides, launched a Phase III trial for a microbicide ring in Rwanda. This will be the third and final stage of testing for the microbicide ring, designed to be self-inserted by a woman and to provide long-term HIV protection. The trial in Rwanda is expected to last three years and will take place simultaneously with similar Phase III testing in Malawi, South Africa, and Zimbabwe. The trials in all four countries will include more than 3,000 HIV negative women between 18 and 40 years of age and are intended to examine efficacy and gather necessary information in order to bring the microbicide ring to market. See the links below for more information.

MORE NEWS

 

Sign up for the GHTC newsletter Follow us

Home | Contact us | Privacy policy | Copyright policy

© 2009–2012, Global Health Technologies Coalition.